Validation of sample size esti­ma­tions? [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2023-05-29 10:34 (388 d 09:43 ago) – Posting: # 23575
Views: 1,319


THX for posting!

An interesting statement in 3.16.2 Statistical Programming and Data Analysis:
  1. The sponsor should ensure that appropriate and documented quality control of statistical programming and data analysis is implemented (e.g., for sample size calculations, …).
This would be a tough cookie in connection with 4.5 Validation of Computerised Systems.

Good luck! For parallel groups, 2×2×2 cross-overs, and RSABE/ABEL sample size tables were published. Regrettably some contain typos or the number of simulations for RSABE/ABEL was too small for a stable result (see this article). You are left out in the rain if you want anything not covered (say, power 85% and/or a T/R-ratio of 0.93). AFAIK, nothing is published for Higher-Order crossovers, Balaam’s design, ABE in replicate designs, the FDA’s ref­er­ence-scaling for NTIDs, and Non-Inferiority / Non-Superiority. IMHO, the only solution would be to get yet another software and perform cross-validation.

Of course, requiring software validation in general is not new. Don’t trust the vendor. Validation always lies in the hand of the user.1–3

  1. ICH. Statistical Principles for Clinical Trials. E9. 5 February 1998. Section 5.8.
  2. FDA. Statistical Software Clarifying Statement. May 6, 2015. Download.
  3. WHO. Guidance for organizations performing in vivo bioequivalence studies. Geneva. May 2016. Technical Report Series No. 996, Annex 9. Section 4.4. Online.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,646 registered users;
29 visitors (0 registered, 29 guests [including 9 identified bots]).
Forum time: 20:18 CEST (Europe/Vienna)

Friends don’t let friends use Excel for statistics!    Jonathan D. Cryer

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz